★ WIDE MOAT STOCKS & COMPETITIVE ADVANTAGES ★
VOL. XCIV, NO. 247
Kenvue Inc.
KVUE · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Request update
Spot something outdated? Send a quick note and source so we can refresh this profile.
Overview
Kenvue is a global consumer health company with Self Care, Skin Health & Beauty, and Essential Health segments. Its defensible advantages are principally brand trust, strongest in heritage OTC medicines, plus a moderate manufacturing and procurement scale benefit. Broad retail distribution, shared marketing capabilities, routine product use, and standard FDA and supplier audits do not independently establish control, scope economies, habit lock-in, or a compliance moat. Q1 2026 organic sales grew 0.7%, with value realization partly offset by lower volume. Kimberly-Clark and Kenvue shareholders approved the pending acquisition on January 29, 2026 and the U.S. HSR waiting period expired February 4; closing remains expected in the second half of 2026 subject to foreign regulatory approvals and other conditions.
Primary segment
Self Care
Market structure
Oligopoly
Market share
—
HHI: —
Coverage
3 segments · 5 tags
Updated 2026-07-12
Segments
Self Care
OTC self-care consumer health products (pain care, cough/cold/allergy, digestive health, smoking cessation, eye care)
Revenue
43.5%
Structure
Oligopoly
Pricing
moderate
Share
—
Peers
Skin Health and Beauty
Mass-market skin and hair care (dermatology-led personal care) consumer health products
Revenue
27.1%
Structure
Competitive
Pricing
weak
Share
—
Peers
Essential Health
Everyday personal care essentials (oral care, baby care, wound care, women's health)
Revenue
29.4%
Structure
Competitive
Pricing
moderate
Share
—
Peers
Moat Claims
Self Care
OTC self-care consumer health products (pain care, cough/cold/allergy, digestive health, smoking cessation, eye care)
Reported segment includes Pain Care; Cough, Cold, and Allergy; and Other Self Care (Digestive Health, Smoking Cessation, Eye Care). Revenue/operating-profit shares derived from Q1 2026 segment net sales ($1.699B) and segment adjusted operating income ($625m). Source: https://www.sec.gov/Archives/edgar/data/1944048/000194404826000098/kvue-20260329.htm
Brand Trust
Demand
Brand Trust
Strength
Durability
Confidence
Evidence
Heritage OTC brands (e.g., Tylenol, Motrin, Zyrtec) reinforced by science/healthcare-professional endorsement support consumer trust and repeat purchase.
Brand Trust moat: definition, examples, and stocks
Erosion risks
- Generic OTC and private-label substitution
- Brand damage from safety/quality incidents or negative publicity
- Regulatory changes impacting OTC labeling/claims
Leading indicators
- Category share trends in Pain Care and Allergy Care
- Brand consideration/NPS and repeat-purchase metrics
- Price gaps vs private label and elasticity in promo periods
Counterarguments
- OTC consumers can switch quickly when price promotions favor rivals or store brands
- Large competitors also have trusted brands and can match marketing spend
Scale Economies Unit Cost
Supply
Scale Economies Unit Cost
Strength
Durability
Confidence
Evidence
Scale manufacturing and global supply agreements support unit-cost leverage and availability for high-volume OTC categories.
Scale Economies Unit Cost moat: definition, examples, and stocks
Erosion risks
- Commodity/input cost inflation outpacing price realization
- Supply chain disruptions or single-source inputs for some products
- Competitors achieving similar scale efficiencies
Leading indicators
- Gross margin and cost-of-goods inflation vs pricing
- Service levels (fill rates) and out-of-stock frequency
- Savings delivered from supply chain optimization programs
Counterarguments
- Scale advantages can be competed away because multiple global CPG peers also operate at large scale
- Retailers can pressure prices, limiting the ability to retain cost savings
Skin Health and Beauty
Mass-market skin and hair care (dermatology-led personal care) consumer health products
Reported segment includes Face and Body Care; and Hair, Sun, and Other. Revenue/operating-profit shares derived from Q1 2026 segment net sales ($1.059B) and segment adjusted operating income ($168m). Source: https://www.sec.gov/Archives/edgar/data/1944048/000194404826000098/kvue-20260329.htm
Brand Trust
Demand
Brand Trust
Strength
Durability
Confidence
Evidence
Brands positioned around dermatological/science-backed efficacy (e.g., Neutrogena, Aveeno) support willingness to pay vs unbranded alternatives.
Brand Trust moat: definition, examples, and stocks
Erosion risks
- Fast-changing beauty trends and influencer-driven niche brands
- Private label expansion and retailer shelf-space pressure
- Execution challenges (in-stock, merchandising) eroding brand momentum
Leading indicators
- Category growth vs Kenvue volume trend and shelf share
- Digital share of voice and review sentiment for key brands
- Promo intensity and net price realization vs competitors
Counterarguments
- Beauty/personal care is fragmented and brand loyalty can be weaker than in OTC medicines
- Premium brands and DTC challengers can out-innovate incumbents
Essential Health
Everyday personal care essentials (oral care, baby care, wound care, women's health)
Reported segment includes Oral Care; Baby Care; and Other Essential Health (Women's Health, Wound Care, and Other). Revenue/operating-profit shares derived from Q1 2026 segment net sales ($1.151B) and segment adjusted operating income ($299m). Source: https://www.sec.gov/Archives/edgar/data/1944048/000194404826000098/kvue-20260329.htm
Brand Trust
Demand
Brand Trust
Strength
Durability
Confidence
Evidence
Household brands (e.g., Listerine, Johnson's, Band-Aid) carry perceived reliability in family and personal care categories.
Brand Trust moat: definition, examples, and stocks
Erosion risks
- Negative publicity affecting brand reputation
- Product quality issues causing long-lasting trust loss
- Category commoditization
Leading indicators
- Brand sentiment/review scores in oral and baby care
- Recall/complaint rates for family-care products
- Net revenue retention via repeat purchase/penetration
Counterarguments
- Trust is not exclusive -- competitors also own strong family-care brands
- In commoditized subcategories, trust has limited pricing impact
Evidence
Built on more than a century of heritage and trusted by generations
Supports durability of brand equity in consumer health categories.
backed by science and recommended by healthcare professionals
Links brand positioning to credibility and reinforcement via healthcare professionals.
benefit from economies of scale and global supply chain agreements
Explicitly claims scale benefits and global procurement leverage.
in-house manufacturing footprint delivered approximately 60% of our sales volume
Indicates meaningful internal capacity (with external partners) that can support service levels and cost optimization.
create differentiated, science-backed products recommended by healthcare professionals
Supports credibility positioning for skin and hair care products.
Showing 5 of 6 sources.
Risks & Indicators
Erosion risks
- Generic OTC and private-label substitution
- Brand damage from safety/quality incidents or negative publicity
- Regulatory changes impacting OTC labeling/claims
- Commodity/input cost inflation outpacing price realization
- Supply chain disruptions or single-source inputs for some products
- Competitors achieving similar scale efficiencies
Leading indicators
- Category share trends in Pain Care and Allergy Care
- Brand consideration/NPS and repeat-purchase metrics
- Price gaps vs private label and elasticity in promo periods
- Gross margin and cost-of-goods inflation vs pricing
- Service levels (fill rates) and out-of-stock frequency
- Savings delivered from supply chain optimization programs
Research KVUE elsewhere
Keep the research going
More Rankings & Systems
Quality Stocks
High quality stocks ranked by profitability, margins, free cash flow quality, durability, solvency, and accounting...
Stock rankingUndervalued Stocks
Undervalued stocks from the NA & Europe universe, ranked with a multi-measure value system and quality controls.
Stock rankingDividend Stocks
Dividend stocks ranked by payout yield, payout sustainability, dividend growth, quality, balance-sheet safety, risk...
Stock rankingDefensive Stocks
Defensive stocks ranked by low volatility, low beta, intermediate momentum, durable profitability, balance sheet...
Stock rankingMomentum Stocks
Momentum stocks ranked by total return momentum, relative momentum, trend confirmation, and risk-adjusted momentum...
Stock rankingConviction 10
A concentrated 10-stock strategy from the NA & Europe universe, ranked across quality, value, growth, momentum, and...
Curation & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.